KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Total Current Liabilities: 2010-2015

Historic Total Current Liabilities for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $64.4 million.

  • Biocryst Pharmaceuticals' Total Current Liabilities rose 29.35% to $64.4 million in Q3 2015 from the same period last year, while for Sep 2015 it was $64.4 million, marking a year-over-year increase of 29.35%. This contributed to the annual value of $57.3 million for FY2014, which is 275.54% up from last year.
  • According to the latest figures from Q3 2015, Biocryst Pharmaceuticals' Total Current Liabilities is $64.4 million, which was up 1.05% from $63.8 million recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Total Current Liabilities ranged from a high of $64.4 million in Q3 2015 and a low of $11.3 million during Q1 2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Total Current Liabilities had a median value of $44.9 million in 2014 and averaged $37.0 million.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Total Current Liabilities plummeted by 37.41% in 2013, and later soared by 351.91% in 2015.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Total Current Liabilities stood at $26.3 million in 2011, then plummeted by 34.51% to $17.2 million in 2012, then fell by 11.43% to $15.3 million in 2013, then skyrocketed by 275.54% to $57.3 million in 2014, then grew by 29.35% to $64.4 million in 2015.
  • Its last three reported values are $64.4 million in Q3 2015, $63.8 million for Q2 2015, and $61.9 million during Q1 2015.